Ambu launches new duodenoscope in four weeks
While Ambu had to disappoint investors with a postponement of the company's new broncoscope, the launch of the company's bright hope, a new version of the company's duodenoscope, is proceeding according to plan. CEO Juan Jose Gonzalez relates that the commercialization is slated to begin in exactly four weeks.
BY ULRICH QUISTGAARD, TRANSLATED BY CHRISTOFFER ØSTERGAARD
The launch of Ambu's new duodenoscope, Ascope Duo 1.5, is proceeding exactly as planned, and while the company's financial report for the staggered notes that the commercialization is set to begin in September, Ambu's CEO has no objections to clarifying further.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Ambu joins green climate initiative
For subscribers
Ambu's Q3 ended better than expected
For subscribers
